|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Bad bugs need drugs, an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America显示文摘 | Talbot GH Bradley J Edwards JE | 2006 | Clin Infect Dis2006，42，5： | 1 |
| 2 | Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America 显示文摘 | Boucher HW Talbot GH Bradley JS | 2009 | Clin Infect Dis2009，48，1： | 1 |
| 3 | Bad bugs,no drugs:no ESKAPE! An update from the Infectious Diseases Society of America显示文摘 | Boucher HW Talbot GH Bradley JS | | 0，，： | 1 |
| 4 | Risk factors for amphotericin B-associated nephrotoxicity显示文摘 | Fisher MA Talbot GH Maislin G | 1989 | Am J Med1989，87，5： | 1 |
| 5 | Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America 显示文摘 | Boucher HW Talbot GH Bradley JS Edwards JE Gilbert D Rice LB Scheld M Spellberg B Bartlett J | 2009 | Clin Infect Dis2009，48，1： | 1 |
| 6 | Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America显示文摘 | Talbot GH Bradley J Edwards JE Jr | 2006 | Clin Infect Dis2006，42，5： | 1 |
| 7 | Considerations in undertaking a clinical development pro-gram for hospital-acquired bacterial pneumonia and/or ventilator-as-sociated bacterial pneumonia 显示文摘 | Talbot GH | 2010 | Clinical infectious diseases: an offi-cial publication of the Infectious Diseases Society of America2010，511，： | 1 |
| 8 | Bad bugs,no drugs:no ESKAPE! An update from the lnfectious Diseases Society of America显示文摘 | Boucher HW Talbot GH Bradley JS | 2009 | Clin Infect Dis2009，48，1： | 1 |
| 9 | Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America显示文摘 | Boucher HW Talbot GH Bradley JS | 2009 | Clin Infect Dis2009，48，1： | 1 |
| 10 | Bad bugs need drugs:an update on the development pipeline from the Antimicrobial A-vailability Task Force of the Infectious Diseases Society of America显示文摘 | Talbot GH Bradley J Edwards JE | 2006 | Clin Infect Dis2006，42，5： | 1 |
| 11 | In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States显示文摘 | Ge Y Biek D Talbot GH | 2008 | Antimicrob Agents Chemother2008，52，9： | 1 |
| 12 | CANVAS 1:the first Phase III,randomized,double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections显示文摘 | Corey GR Wilcox MH Talbot GH | | J Antimicrob Chemotherapy0，65，4： | 1 |
| 13 | Invasive pulmona ry aspergi显示文摘 | Gefter WB Albelda SM Talbot GH | 1985 | Radiology1985，157，3： | 1 |
| 14 | 10 ×20 Progress-development of new drugsactive against gram-nega- tive bacilli: an update from the Infectious Diseases Society of A- merica 显示文摘 | BOUCHER HW TALBOT GH BENJAMIN DK JR | 2013 | Clin Infect Dis2013，56，12： | 1 |
| 15 | CANVAS 2:the second Phase III,randomized,double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections显示文摘 | Wilcox MH Corey GR Talbot GH | | J Antimicrob Chemotherapy0，65，14： | 1 |
| 16 | Once - weekly dalbavancin versus daily conventional therapy for skin infection 显示文摘 | Boucher HW Wilcox M Talbot GH | 2014 | N Engl J Med2014，370，23： | 1 |
| 17 | The antibiotic development pipeline for multidrug - resistant gram - negative bacilli: current and future landscapes显示文摘 | Talbot GH | 2010 | Infect Control Hosp Epidemiol2010，31，1： | 1 |
| 18 | Phase 2 study of ceftaroline versus standard therapy in treatment of complicated skin and skin structure infections 显示文摘 | Talbot GH Thye D Das A | 2007 | Antimicrob Agents Chemother2007，51，10： | 1 |
| 19 | Rigid nasal endoscopy versus sinus puncture and aspiration for microbiologic documentation of acute bacterial maxillary sinusitis 显示文摘 | Talbot GH Kennedy DW Scheld WM | 2001 | Clin Infect Dis2001，33，： | 1 |
| 20 | CANVAS 1 : the first Phase Ⅲ, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections 显示文摘 | Corey GR Wilcox MH Talbot GH | 2010 | J Antimicrob Chemother2010，654，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员